LL: nm [15-180] water 22/62 redo surgery continence and satisfaction FI: nm Questionnaire: 32 responded (p=.04) Constipation: from 51 still using ACE nm Casale et al, N= 275 SB FU: 45-120 Not defined Single centre 94% continence, no difference Not evaluated 06 33 Age: mean months Retrospective chart review between groups 11y TT: nm 215 Malone ACE 27% complications, no LL: nm Single surgery compared to difference between groups FI: nm combined urologic surgery Constipation: (n=158) nm Lemelle et al, N= 423 SB FU: 36 5 point Likert Multicentre 6 dropped out Not evaluated 06 34 Age: 10-47y months scale Clinical interview and medical ACE group is significant younger 145 TT: 50min (1=permanent, chart review ACE group significant less FI wheelchair [15-90] 2=frequent, Right ACE: 40, left ACE: 7, 1.2L Left ACE tends to shorter LL: nm 3=occasional, tap or saline water defecation time and worse FI FI: nm 4=rare, Conventional treated group Constipation: 5=never) (n=382) compared to ACE group nm (n=41) Bani-Hani et N= 236, 199 FU: 50 No stool loss Single centre 196/236 (83%) continence rose Not evaluated al, 08 35 SB months Retrospective chart review to 221/236 (94%) using Age: 2-36y TT: nm Malone ACE daily 642ml tap additives LL: nm water FI: nm Evaluation of use of additives: Constipation: - immediate FI: larger volume or nm more time on toilet - midday FI: bowel cleanout and add 17mg MiraLAX Cain et al, 08 N= 236, 199 FU: 50 No stool loss Single centre 221/236 (94%) continent Not evaluated 36 SB months Retrospective chart review 98/236 complications Age: 2-36y TT: nm Malone ACE daily, 642ml tap 51/236 redo surgery LL: nm water FI: nm Constipation: nm
LL: nm FI: nm Constipation: nm [15-180] water Questionnaire: 32 responded from 51 still using ACE 22/62 redo surgery continence and satisfaction (p=.04) Casale et al, 06 33 N= 275 SB Age: mean 11y LL: nm FI: nm Constipation: nm FU: 45-120 months TT: nm Not defined Single centre Retrospective chart review 215 Malone ACE Single surgery compared to combined urologic surgery (n=158) 94% continence, no difference between groups 27% complications, no difference between groups Not evaluated Lemelle et al, 06 34 N= 423 SB Age: 10-47y 145 wheelchair LL: nm FI: nm Constipation: nm FU: 36 months TT: 50min [15-90] 5 point Likert scale (1=permanent, 2=frequent, 3=occasional, 4=rare, 5=never) Multicentre Clinical interview and medical chart review Right ACE: 40, left ACE: 7, 1.2L tap or saline water Conventional treated group (n=382) compared to ACE group (n=41) 6 dropped out ACE group is significant younger ACE group significant less FI Left ACE tends to shorter defecation time and worse FI Not evaluated Bani-Hani et al, 08 35 N= 236, 199 SB Age: 2-36y LL: nm FI: nm Constipation: nm FU: 50 months TT: nm No stool loss Single centre Retrospective chart review Malone ACE daily 642ml tap water Evaluation of use of additives: - immediate FI: larger volume or more time on toilet - midday FI: bowel cleanout and add 17mg MiraLAX 196/236 (83%) continence rose to 221/236 (94%) using additives Not evaluated Cain et al, 08 36 N= 236, 199 SB Age: 2-36y LL: nm FI: nm Constipation: nm FU: 50 months TT: nm No stool loss Single centre Retrospective chart review Malone ACE daily, 642ml tap water 221/236 (94%) continent 98/236 complications 51/236 redo surgery Not evaluated
4170206.docx